Avacopan for the Treatment of ANCA-Associated Vasculitis

Overview of attention for article published in New England Journal of Medicine, February 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 30 news outlets
blogs: 6 blogs
policy: 2 policy sources
twitter: 393 X users
patent: 6 patents
facebook: 4 Facebook pages

wikipedia: 4 Wikipedia pages
reddit: 1 Redditor
f1000: 1 research highlight platform
guideline: 8 clinical guideline sources
bluesky: 5 Bluesky users
podcasts: 6 podcasts

Readers on

mendeley: 627 Mendeley

So far, Altmetric has seen 479 X posts from 393 X users, with an upper bound of 1,370,574 followers.

@kidney_boy https://t.co/7BWLqkoZsu

@jasonryanmd Por qué lo dudas si NEJM ya se retractó https://t.co/crHYcB7AnJ

RETRACTED: Avacopan for the Treatment of ANCA-Associated Vasculitis | New England Journal of Medicine https://t.co/5cwfs1Ex5C @RheumNow

RT @EARL_med_tw: 投与後20人死亡のANCA血管炎治療薬タブネオス®︎（アバコパン）のADVOCATE Study（NEJM）論文が撤回元論文 https://t.co/XUk4BEiYrn 撤回通知 https://t.co/JJUIwTX1Ii htt…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 475 additional X posts.